Neurophet Supplies ‘Neurophet AQUA’ to Raffles Medical in Singapore
Providing Neurophet AQUA capable of analyzing brain atrophy and white matter degeneration… Securing meaningful clinical referenceSEOUL, South Korea, July 2,...
Providing Neurophet AQUA capable of analyzing brain atrophy and white matter degeneration… Securing meaningful clinical referenceSEOUL, South Korea, July 2,...
First gene replacement therapy in the EU for broad population with SMA, including children two years and older, teens and...
New npj Parkinson's Disease publication, building on the previously reported Hybridopa™ Phase IIa results, demonstrates for the first time, that...
NEWARK, Del., June 30, 2026 /PRNewswire/ -- The global Magnetic Resonance Imaging (MRI) Market, according to Future Market Insights, is...
Florida's premier health information management conference welcomes hundreds of healthcare professionals to Orlando, July 12–15, 2026.ORLANDO, Fla., June 30, 2026...
In this free webinar brought to you by Xtalks Life Sciences United (XLSU), see how advocacy perspectives can help shape...
Pre-qualified global site network aligned to Allucent's therapeutic Centers of Expertise (ACEs)Defined execution commitments for feasibility, startup, and enrollmentBuilt on...
Recently disclosed longer-term REVEAL Part A data demonstrated broad, multi-domain functional impact that deepened over time through ≥12 months post-TSHA-102...
Next generation, dual-use robotics and navigation platform allows for surgical guidance tailored to surgeon preference and the patient SOMERS POINT,...
A Platform Built for Clarity and ConnectionNEW YORK, June 24, 2026 /PRNewswire/ -- Digital Silk led the engagement from strategy...
Rapidly growing pharmaceutical services platform receives industry recognition NASHVILLE, Tenn., June 24, 2026 /PRNewswire/ -- Petauri, a purpose-built pharmaceutical services platform,...
In this free webinar, gain insight into how patient identification approaches can improve study efficiency in precision neurology programs. Attendees...
TEL AVIV, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that...
NDA submission supported by positive Phase 3 data recently published in JAMA Neurology.Ecopipam is a first-in-class selective dopamine D1 receptor...
TEL AVIV, Israel and PARSIPPANY, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA)...
Collaboration aims to identify biomarkers predictive of antibody-drug conjugate (ADC) treatment response using 10x's single cell and spatial platformsPLEASANTON, Calif.,...
Collaboration aims to identify biomarkers predictive of antibody-drug conjugate (ADC) treatment response using 10x's single cell and spatial platformsPLEASANTON, Calif.,...
BOULDER, Colo., June 17, 2026 /PRNewswire/ -- Igniton is proud to announce that it has been honored with three 2025...
Aarhus, Denmark, 17 June 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore...
Introduces key products including an integrated brain imaging analysis solution for Alzheimer's disease treatment decision-makingExpands partnering efforts with global pharmaceutical...